• Amitriptyline HCl: Applied Research Workflows

  2026-08-13

  A practical guide to using Amitriptyline HCl in receptor, pathway, viability, and blood-brain barrier workflows. It combines concentration planning, fresh-solution handling, orthogonal readouts, and a cautious lipidomics-inspired framework for mechanistic studies.

• VX-702: Reading p38α MAPK Inhibition in Context

  2026-08-13

  VX-702 is a selective p38α MAPK inhibitor whose value extends beyond a low-nanomolar IC50. This article explains how activation-loop dynamics, phosphatase activity, cytokine readouts, and model-specific controls can improve interpretation in inflammation and cardiovascular research.

• Baicalin Reactivates Adult Visual Plasticity in Amblyopia

  2026-08-12

  A 2026 NeuroImage study found that baicalin reactivated ocular dominance plasticity in adult amblyopic mice, with 10 mg/kg treatment restoring cortical eye preference and visual acuity when paired with reverse suturing. Imaging, electrophysiology, inhibitory-marker analysis, and muscimol blockade together implicate reduced GABAergic inhibition as an important permissive mechanism.

• ARCA Cy3 EGFP mRNA (5-moUTP): Workflow Guide

  2026-08-12

  Build a two-signal assay that tracks mRNA uptake with Cy3 while measuring downstream EGFP translation. This workflow helps distinguish delivery, intracellular localization, endosomal escape, and protein expression during mRNA transfection in mammalian cells.

• Rapamycin, TFEB, and the Next mTOR Strategy

  2026-08-11

  Rapamycin is more than a potent mTOR pathway probe. Its value in translational research lies in connecting target engagement with adaptive immune escape, metabolic remodeling, and context-specific phenotypes. This article outlines how to use Sirolimus strategically across cancer, immunology, and mitochondrial disease models.

• 2-D08 for Selective Sumoylation Workflows

  2026-08-10

  2-D08 enables targeted interrogation of UBC9-dependent SUMO transfer without directly blocking SUMO E1 activation or global ubiquitination. This article presents practical workflows for cancer cell line sumoylation studies, mechanistic validation, and exploratory mitophagy research while clearly separating established evidence from recommended assay starting points.

• Vincristine Sulfate: Designing Better Cancer Assays

  2026-08-09

  Vincristine sulfate is a powerful tool for studying tubulin polymerization, microtubule dynamics, and cancer-cell proliferation. This assay-centered guide connects molecular mechanism, experimental design, and evidence interpretation while clarifying how a systematic review methodology can improve cancer research decisions.

• CARMIL Membrane Binding and Actin Assembly

  2026-08-08

  The reference preprint identifies the CARMIL membrane-binding domain as an active regulator of capping protein, rather than a passive membrane-targeting sequence. Biochemical reconstitution shows that the domain can recruit CARMIL-associated capping activity to lipid surfaces, then dissociate after capping protein binding to promote uncapping and soluble actin assembly.

• DIDS Workflows for Chloride and Tumor Stress

  2026-08-07

  DIDS enables practical interrogation of chloride transport, TRPV1-dependent currents, vascular tone, and stress-surviving tumor-cell states. This guide combines concentration-aware assay design with workflow controls that help distinguish target-linked effects from solubility, vehicle, and cytotoxicity artifacts.

• Hydrazide-Based VEGFR-2 Inhibitors: Antiangiogenic Potential

  2026-08-07

  This study presents the synthesis and evaluation of 53 hydrazide-based derivatives as VEGFR-2 inhibitors, highlighting SA7 as a potent lead with antiangiogenic and antiproliferative activity. The findings position these novel compounds as promising alternatives to established agents like sorafenib for targeting tumor angiogenesis and growth.

• tRF16-ALKBH5 Axis Regulates OA Progression via m6A Modulatio

  2026-08-06

  This study identifies the tRNA-derived fragment tRF16 as a regulator of osteoarthritis (OA) progression through m6A-dependent destabilization of NFKBIA mRNA. By elucidating how tRF16 targets ALKBH5 to activate NF-κB signaling, the research provides mechanistic insight and potential biomarker relevance for OA diagnosis and intervention.

• Berberine Modulates RXRα/PPARγ/NEDD4 to Limit SASP in Athero

  2026-08-06

  The referenced study uncovers how berberine inhibits SASP-driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. These mechanistic insights reveal potential new targets for modulating vascular aging and chronic inflammation.

• Differential SHH Expression Drives Species-Specific Penile D

  2026-08-05

  This study uncovers how differences in Sonic Hedgehog (Shh), Fgf10, and Fgfr2 gene expression determine divergent mechanisms of prepuce and urethral groove formation in guinea pigs versus mice. By integrating gene expression profiling and functional assays, the research clarifies why guinea pigs and humans develop a fully open urethral groove, with implications for congenital malformation modeling.

• Npt1-Mediated Renal Secretion of Faropenem Sodium: Mechanist

  2026-08-05

  The reference study uncovers how the renal luminal inorganic phosphate transporter Npt1 mediates secretion of faropenem sodium, a penem antibiotic, clarifying the molecular basis for its elimination. These findings inform pharmacokinetic modeling, resistance studies, and rational antibiotic selection in infection research.

• SU5416 (Semaxanib): Precision VEGFR2 Inhibition in Cancer Re

  2026-08-04

  SU5416 (Semaxanib) sets a benchmark for selective VEGFR2 inhibition, pairing robust anti-angiogenic activity with unique immune modulation capabilities. This guide delivers advanced experimental workflows, troubleshooting insights, and protocol parameters to maximize reproducibility and data quality in translational cancer and vascular studies.

479 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page